Discover the Cipla Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock.

The presence of multinational pharma companies (MNCs) in India's drug market continues to shrink, reaching 14.5% in May 2025 ...

Cipla's India operations certified water positive by Bureau Veritas. Reduced water withdrawal by 13.1% and 50% water recycled ...

Key pharma stocks, including Granules India and Gland Pharma, have shown substantial recovery, with the Nifty Pharma index ...

Are you looking for dividend-paying stocks in June 2025? This month is packed with major companies announcing final and ...

With Cipla's shares showing a gain of 0.55% to reach Rs 1,481.30, the stock reflects ongoing market activity in the ...

Eli Lilly's weight-loss and diabetes drug, Mounjaro, has experienced a 60% sales increase in India between April and May.

According to Moneycontrol analysis, the market sentiment for Cipla is Very Bearish as of June 3, 2025. Cipla is included in ...

Cipla Ltd has announced that the United States Food and Drug Administration (USFDA), has recently completed cGMP inspection ...

Mumbai: Cipla has announced the appointment of Prabhakaran Balakrishnan Nair, presently working as Chief of Quality - Indore ...

InCred Capital booked profits in Adani Port and exited Cipla due to margin concerns, while introducing Camlin Life Science, ...

March quarter earnings brought relief to the Indian stock market as corporate performance exceeded estimates. Nifty 50 ...